When everything has to happen at once
The why
The challenge
The organisation faced a dilemma: It had to build the organisation and sell its services before the facility existed to deliver them. Construction, commercial pipeline development, hiring, and operational readiness were all running in parallel – each with hard sequencing dependencies and little room to recover from mistiming.
There was no integrated view of how these workstreams connected. In cell therapy, where customer lead times routinely exceed a year, this gap carried concrete commercial risk: Arrive at launch without a pipeline and the facility opens underutilised.
Strategic positioning added further complication. The executive team was reluctant to rule out opportunities in a rapidly evolving market – understandable, but risky. Broad positioning meant diffuse capability investment, unclear hiring profiles, and a commercial story that was hard to land with early customers who needed specificity before they would commit.
Without a clear organisational development plan (ODP), the organisation risked arriving at launch having built the wrong organisation for the strategy.
How we helped
We began with a two-day facilitated offsite for the full executive leadership team, designed to surface misaligned assumptions, establish shared priorities, and define the design principles that would govern the ODP.
Over the following weeks, we detailed the foundation for the ODP across two workstreams. We ran focused working sessions with internal stakeholders to map dependencies and operational constraints that executive-level planning tends to miss. In parallel, we benchmarked international peer CDMOs, speaking directly with leaders who had navigated comparable ramp-ups, to pressure-test our assumptions.
We consolidated all inputs into a four-year organisational development plan with activity sequencing, milestones, and initiative briefs. To ensure organisational anchoring and disciplined execution, we developed supporting governance and facilitation tools.
Outcome
Benchmark insights
Build the pipeline before the facility is ready: Customer cycles are long, requiring commercial engagement earlier than what feels comfortable.
Hire leaders first: Fill leadership before filling roles. Organisations that did it the other way struggled with retention and coherence during scale-up.
What moved the needle
The executive team moved from broad ambition to a concrete roadmap. But three specific choices made the difference between a plan that would be used and one that would quickly become obsolete.Daniel Schmidt
Daniel works with life science executives to design strategies, operating models, and transformation programs. He brings both functional depth and board-level perspectives, helping senior leaders navigate complexity and make clear choices. He formerly led the life science practice at Deloitte Denmark.
Daniel holds a B.Sc. in International Business and an M.Sc. in Economics and Business Administration from Copenhagen Business School.
- TA strategy for immunology portfolio
- Strategy for application and value realisation of AI across R&D
- Business model design for new innovative business unit
- Global digital transformation across commercial functions
Florian Preis
Florian is a life science strategist supporting pharma and biotech leaders shape therapeutic area and launch performance. He is an expert in translating global strategic direction into market-level execution, and in the operating models that make it hold. He works hypothesis-led and close to the client, bringing a point of view early and sharpening it through rigorous analysis.
Florian holds an M.Sc. in Advanced Economics and Finance from Copenhagen Business School, CBS. He brings experience from both strategy consulting and the pharmaceutical industry.
- Therapeutic area strategy and portfolio prioritisation
- Launch readiness for cardiovascular and metabolic assets
- Global-to-local strategy translation and affiliate activation
- Operating model design for cell and gene therapy CDMO